Advertisement
News
Subscribe to MDT Magazine News

Nimbus gets seed funding co-led by Bill Gates

March 10, 2011 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based Nimbus Discovery LLC, which uses computational technology to discover novel medicines, said today that it has extended its seed round with an investment by Microsoft Corp. founder Bill Gates, Schrödinger co-founder Richard Friesner and Atlas Ventures.

InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

LOS ANGELES, March 10, 2011 /- InstaCare Corp. (OTC Bulletin Board: ISCR ), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary patent...

TOPICS:

MPO Symposium Offers Medical Device Manufacturers the Opportunity to Tour Plants in Costa Rica

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

RAMSEY, N.J., March 10, 2011 /- As part of a two-day education and networking event, MPO Symposium provides medical device manufacturers rare access to local facilities in and around San Jose, Costa Rica, following a morning of conference sessions on May 11. As part of your conference...

TOPICS:
Advertisement

Remedi SeniorCare Expands Distribution of the Paxitâ„¢ Med-Pass Solution, the New Standard in Medication Administration

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

BALTIMORE, March 10, 2011 /- Remedi SeniorCare®, which is among the nation's largest independent institutional pharmacies, is revolutionizing the long-term care (LTC) pharmacy industry with the Paxit™ med-pass system, its 24-hour unit dose medication administration system...

TOPICS:

Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

WAYLAND, Mass., March 10, 2011 /- Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small...

TOPICS:

PNP Therapeutics Meets Important Financial and Regulatory Objectives in Development of New Cancer Therapies

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

BIRMINGHAM, Ala., March 10, 2011 /- PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham (UAB) — today announced that several major...

TOPICS:

Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, March 10, 2011 /- American Medical Systems® (AMS) (Nasdaq: AMMD ), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the results of a six-month prospective multi-center study of the Elevate® Anterior and...

TOPICS:

Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million

March 10, 2011 6:35 am | by Bio-Medicine.Org | Comments

WASHINGTON, March 10, 2011 /PRNewswire-USNewswire/ -- As Florida legislators seek ways to reduce Medicaid spending, they should start by transitioning the entire pharmacy benefits program from the archaic fee-for-service model to the more efficient model used in some parts of the state. A...

TOPICS:
Advertisement

Untitled

March 10, 2011 5:35 am | by International Osteoporosis Foundation | Comments

More than 4000 already registered! Online registration still open at www.ecceo11-iof.org

TOPICS:

Exelixis expects $155.9M from stock offering

March 10, 2011 4:45 am | by The Associated Press | Comments

SOUTH SAN FRANCISCO, Calif. (AP) — Cancer drug developer Exelixis Inc. on Thursday expanded a public offering of its stock, and it expects to raise $155.9 million from the sale after expenses.Exelixis said it will sell 15 million shares at $11 per share. The company priced the offering at a...

Chiasma caps debt round at a new $9M high

March 10, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Barely two months after it last increased it's latest debt financing round, Chiasma Inc. has kicked it up again, this time climbing from a planned $6 million to a completed $9 million total.

Echo Therapeutics to Present at the ROTH 23rd Annual Growth Stock Conference

March 10, 2011 4:37 am | by Bio-Medicine.Org | Comments

FRANKLIN, Mass., March 10, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal...

TOPICS:

OXIS International to Hold Business Update Conference Call on March 22

March 10, 2011 4:36 am | by Bio-Medicine.Org | Comments

BEVERLY HILLS, Calif., March 10, 2011 /- OXIS International, Inc., (OTC Bulletin Board: OXIS ;  Paris: OXI) today announced that it will hold a conference call with investors on Tuesday, March 22, 2011 at 11:00 a.m. Eastern (8:00 a.m. Pacific). During the call Anthony Cataldo, Chief...

TOPICS:

Caliper Life Sciences and HistoRx to Provide Integrated Solutions for Superior Protein Quantification of Biomarkers in Tissue

March 10, 2011 4:35 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass. and BRANFORD, Conn., March 10, 2011 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ) and HistoRx, Inc., today announced a collaboration to co-develop a new generation of tissue-based imaging and analysis solutions, based on immuno-fluorescence, that will deliver accurate,...

TOPICS:

TSX to open lower; commodities slip as China surprises with trade deficit

March 10, 2011 3:45 am | by Malcolm Morrison-Associated Press | Comments

The Toronto stock market headed for a lower open Thursday as prices for oil and metals slid in the wake of disappointing trade data from China.Soft commodity prices helped push the Canadian dollar down 0.28 of a cent to 102.95 cents US.U.S. futures were lower after China reported a surprise...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading